• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Tobacco Products

This Week in CTP – January 17, 2014

This Week in CTP - Updates from the Center for Tobacco Products

CTP is pleased to recognize today’s release of the 50th Anniversary Surgeon General’s Report, “The Health Consequences of Smoking—50 Years of Progress.” The Surgeon General’s Report provides a scientific foundation for public health action to reduce the impact of tobacco use. Today’s historic report adds new scientific evidence that further defines the scope of the problem before us: liver cancer, colorectal cancer, diabetes mellitus, and rheumatoid arthritis are now known to be caused by smoking and secondhand smoke exposure is now known to cause stroke.

Approximately four years ago, the FDA received a clear mandate when Congress passed the Family Smoking Prevention and Tobacco Control Act to add tobacco product regulation to the arsenal of tobacco control strategies. As a result, FDA takes science-based action in order to reduce the impact of tobacco products, and considers both users and nonusers. FDA is funding and conducting regulatory science research on tobacco products, enforcing the laws that reduce the access and attractiveness of tobacco products to young people, and preparing to launch an unprecedented national public education campaign to prevent youth tobacco use.

CTP welcomes the vision outlined in today’s Surgeon General’s Report and will continue to propose and implement tobacco product regulations to protect our nation’s health. For more information about the report, read FDA Commissioner Margaret A. Hamburg's statement.